1-5 of 5
Ivana Gojo
Close
Sort by
Journal Articles

Allogeneic transplantation for Ph + acute lymphoblastic leukemia with posttransplantation cyclophosphamide

Clinical Trials & Observations
Jonathan A. Webster, Leo Luznik, Hua-Ling Tsai, Philip H. Imus, Amy E. DeZern, Keith W. Pratz, Mark J. Levis, Ivana Gojo, Margaret M. Showel, Gabrielle Prince, Javier Bolaños-Meade, Lukasz P. Gondek, Gabriel Ghiaur, W. Brian Dalton, Tania Jain, Ephraim J. Fuchs, Douglas E. Gladstone, Christian B. Gocke, Syed Abbas Ali, Carol Ann Huff, Ivan M. Borrello, Lode Swinnen, Nina Wagner-Johnston, Richard F. Ambinder, Richard J. Jones, B. Douglas Smith
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5078–5088.
https://doi.org/10.1182/bloodadvances.2020002945
Published: 2020
Includes: Supplemental data
Journal Articles

TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

Clinical Trials & Observations
Jayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, Sarah E. Church, Tressa Hood, Anbarasu Lourdusamy, Michael P. Rettig, Ibrahim Aldoss, Anjali S. Advani, John Godwin, Matthew J. Wieduwilt, Martha Arellano, John Muth, Tung On Yau, Farhad Ravandi, Kendra Sweet, Heidi Altmann, Gemma A. Foulds, Friedrich Stölzel, Jan Moritz Middeke, Marilena Ciciarello, Antonio Curti, Peter J. M. Valk, Bob Löwenberg, Ivana Gojo, Martin Bornhäuser, John F. DiPersio, Jan K. Davidson-Moncada, Sergio Rutella
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5011–5024.
https://doi.org/10.1182/bloodadvances.2020002512
Published: 2020
Includes: Supplemental data
Journal Articles

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Clinical Trials & Observations
Heather J. Symons, Marianna Zahurak, Yilin Cao, Allen Chen, Kenneth Cooke, Christopher Gamper, Orly Klein, Nicolas Llosa, Elias T. Zambidis, Richard Ambinder, Javier Bolaños-Meade, Ivan Borrello, Robert Brodsky, Amy DeZern, Ivana Gojo, Margaret Showel, Lode Swinnen, B. Douglas Smith, Leo Luznik, Richard J. Jones, Ephraim J. Fuchs
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3913–3925.
https://doi.org/10.1182/bloodadvances.2020001648
Published: 2020
Includes: Supplemental data
Journal Articles

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing

W. Brian Dalton, Eric Helmenstine, Lisa Pieterse, Bing Li, Christopher D. Gocke, Joshua Donaldson, Zhijian Xiao, Lukasz P. Gondek, Gabriel Ghiaur, Ivana Gojo, B. Douglas Smith, Mark J. Levis, Amy E. DeZern
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1192–1196.
https://doi.org/10.1182/bloodadvances.2019001127
Published: 2020
Includes: Supplemental data
Journal Articles

Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide

Laura K. Schoch, Kenneth R. Cooke, Nina D. Wagner-Johnston, Ivana Gojo, Lode J. Swinnen, Philip Imus, Ephraim J. Fuchs, Mark Levis, Richard F. Ambinder, Richard J. Jones, Douglas E. Gladstone
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2226–2229.
https://doi.org/10.1182/bloodadvances.2018019208
Published: 2018